Firy Inc. vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Firy Inc. trades at $12.19 (market cap $199.80M), while Iovance Biotherapeutics Inc. Common Stock trades at $14.47 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 30.2× Firy Inc.'s market cap, and Firy Inc. is more actively traded (92,993 versus 14,805,993). Which is the better fit depends on your goals — on Pluang, investors hold Firy Inc. for 13 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| FIRY | IOVA | |
|---|---|---|
Market Cap | $199.80M | $6.04B |
Volume | 92,993 | 14,805,993 |
Sector | Technology | Health |
52-Week High | $13.10 | $14.82 |
52-Week Low | $2.28 | $1.81 |
Typical Hold Time | 13 Days | 0 Days |
Enterprise Value | $168.40M | $5.97B |
Signals from Pluang's Aura AI — not financial advice
FIRY (formerly Skillz Inc.) trades at $11.85, down 5.05% today, with a bullish technical signal from moving averages despite negative fundamental metrics. The company reported Q2 2026 revenue of $31.0 million but missed EPS expectations with a net loss. Recent developments include a $719 million legal victory against Papaya Gaming and the appointment of Marc Lasry to the board, though cash burn remains elevated at -$86.41M for 2025.
The outlook remains challenged by persistent losses and negative margins, but potential collection of the legal judgment could provide significant upside. Risks include execution on cost controls and uncertainty around Papaya Gaming debt settlement. Analyst sentiment is mixed with 20% buy ratings amid high volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →